(Q36346373)

13 August 2017

1 reference

title

Overactive bladder in the elderly: a guide to pharmacological management (English)

1 reference

13 August 2017

David R Staskin

1

1 reference

13 August 2017

publication date

1 January 2005

1 reference

13 August 2017

1 reference

13 August 2017

volume

22

1 reference

13 August 2017

issue

12

1 reference

13 August 2017

page(s)

1013-1028

1 reference

Urinary incontinence: does it increase risk for falls and fractures? Study of Osteoporotic Fractures Research Group

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200522120-00003

The M2 muscarinic receptor mediates in vitro bladder contractions from patients with neurogenic bladder dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200522120-00003

Treatment of overactive bladder in the older patient: pooled analysis of three phase III studies of darifenacin, an M3 selective receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200522120-00003

Anticholinergic effects of drugs commonly prescribed for the elderly: potential means for assessing risk of delirium

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200522120-00003

Identification of medications that cause cognitive impairment in older people: the case of oxybutynin chloride

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200522120-00003

Bladder activation: afferent mechanisms

21 January 2018

1 reference

12 December 2020

Evaluation of a new once-daily formulation of oxbutynin for the treatment of urinary urge incontinence. Ditropan XL Study Group

1 reference

12 December 2020

Assessment of cognitive function of the elderly population: effects of darifenacin

1 reference

12 December 2020

Multicenter phase III trial studying trospium chloride in patients with overactive bladder

1 reference

12 December 2020

New concepts in relation to urge and detrusor activity

1 reference

12 December 2020

Test-retest reliability of four questionnaires for patients with overactive bladder: the overactive bladder questionnaire (OAB-q), patient perception of bladder condition (PPBC), urgency questionnaire (UQ), and the primary OAB symptom questionnaire

1 reference

12 December 2020

The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society

1 reference

12 December 2020

Medically recognized urinary incontinence and risks of hospitalization, nursing home admission and mortality

1 reference

12 December 2020

Clinical pharmacokinetics of trospium chloride

1 reference

12 December 2020

Effect of trospium chloride on somnolence and sleepiness in patients with overactive bladder

1 reference

12 December 2020

Prevalence and burden of overactive bladder in the United States

1 reference

12 December 2020

Tolterodine: superior tolerability than and comparable efficacy to oxybutynin in individuals 50 years old or older with overactive bladder: a randomized controlled trial

1 reference

12 December 2020

Lower Urinary Tract Symptoms in Men and Women Without Underlying Disease Causing Micturition Disorder: A Cross-Sectional Study Assessing the Natural History of Bladder Function

1 reference

12 December 2020

Urodynamic changes associated with behavioral and drug treatment of urge incontinence in older women

1 reference

12 December 2020

Effects of tolterodine, trospium chloride, and oxybutynin on the central nervous system

1 reference

12 December 2020

Antimuscarinics and the overactive detrusor--which is the main mechanism of action?

1 reference

12 December 2020

1 reference

12 December 2020

Detrusor overactivity. Does it represent a difference if patients feel the involuntary contractions?

1 reference

12 December 2020

A neurologic basis for the overactive bladder

1 reference

12 December 2020

Darifenacin: a novel M3 muscarinic selective receptor antagonist for the treatment of overactive bladder

1 reference

12 December 2020

The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association

1 reference

12 December 2020

Annual direct cost of urinary incontinence.

1 reference

12 December 2020

Influences of trospium chloride and oxybutynin on quantitative EEG in healthy volunteers

1 reference

12 December 2020

Randomized, double-blind placebo- and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder

1 reference

12 December 2020

Oxybutynin with bladder retraining for detrusor instability in elderly people: a randomized controlled trial

1 reference

12 December 2020

Efficacy and safety of transdermal oxybutynin in patients with urge and mixed urinary incontinence

1 reference

12 December 2020

Combined behavioral and drug therapy for urge incontinence in older women

1 reference

12 December 2020

1 reference

12 December 2020

Validation of the urgency perception scale

1 reference

12 December 2020

The management of urinary incontinence in the elderly

1 reference

12 December 2020

Special considerations in premenopausal and postmenopausal women with symptoms of overactive bladder.

1 reference

12 December 2020

Efficacy, safety, and tolerability of extended-release once-daily tolterodine treatment for overactive bladder in older versus younger patients

1 reference

12 December 2020

Whole body distribution of the quaternary ammonium compound thiazinamium (N-methylpromethazine) and promethazine in monkey and mice

1 reference

12 December 2020

Management of overactive bladder

1 reference

12 December 2020

Structural basis of geriatric voiding dysfunction. III. Detrusor overactivity

1 reference

12 December 2020

Effect of aging on the blood-brain barrier

1 reference

12 December 2020

Trospium chloride in the management of overactive bladder

1 reference

12 December 2020

Urge incontinence: the patient's perspective

1 reference

12 December 2020

Aging and its effect on the bladder

1 reference

12 December 2020

Medical therapy for the overactive bladder in the elderly

1 reference

12 December 2020

Urinary infection in old age.

1 reference

12 December 2020

Transient memory impairment and hallucinations associated with tolterodine use.

1 reference

12 December 2020

How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study

1 reference

12 December 2020

Tolterodine: a safe and effective treatment for older patients with overactive bladder

1 reference

12 December 2020

Trospium chloride improves overactive bladder symptoms: a multicenter phase III trial

1 reference

12 December 2020

Protein analysis in cerebrospinal fluid. II. Reference values derived from healthy individuals 18-88 years of age.

1 reference

12 December 2020

Comparative efficacy and safety of transdermal oxybutynin and oral tolterodine versus placebo in previously treated patients with urge and mixed urinary incontinence

1 reference

12 December 2020

Visual hallucinations at the onset of tolterodine treatment in a patient with a high-level spinal cord injury

1 reference

12 December 2020

Controlled, double-blind, multicentre clinical trial to investigate long-term tolerability and efficacy of trospium chloride in patients with detrusor instability

1 reference

12 December 2020

Clinical Pharmacokinetics of Drugs Used to Treat Urge Incontinence

1 reference

12 December 2020

Geriatric incontinence

1 reference

12 December 2020

Behavioral vs Drug Treatment for Urge Urinary Incontinence in Older Women

1 reference

12 December 2020

Oxybutynin extended-release: a review of its use in the management of overactive bladder

1 reference

12 December 2020

Tolterodine and memory: dry but forgetful

1 reference

12 December 2020

Prospective, randomized, double-blind study of the efficacy and tolerability of the extended-release formulations of oxybutynin and tolterodine for overactive bladder: results of the OPERA trial

1 reference

12 December 2020

Tolterodine: a review of its use in the treatment of overactive bladder

1 reference

12 December 2020

Muscarinic receptor antagonists in the treatment of overactive bladder

1 reference

12 December 2020

Serum anticholinergic activity in a community-based sample of older adults: relationship with cognitive performance.

1 reference

12 December 2020

Effects on sleep of anticholinergics used for overactive bladder treatment in healthy volunteers aged > or = 50 years

1 reference

12 December 2020

Urodynamic verification of an overactive bladder is not a prerequisite for antimuscarinic treatment response

1 reference

12 December 2020

Polypharmacy and its effect on urinary incontinence in a geriatric population

1 reference

12 December 2020

Hallucinations with tolterodine

1 reference

12 December 2020

Randomized, double-blind placebo controlled trial of the once daily antimuscarinic agent solifenacin succinate in patients with overactive bladder

1 reference

12 December 2020

10.2165/00002512-200522120-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

13 August 2017

1014318223

0 references

1 reference